BRAG Q1 2026 Earnings EPS Surpasses Estimates Amid Prudent Cost Controls Ernexa Therapeutics Inc ERNA Q3 2023 Earnings Narrowing Losses Amidst Pipeline Progress FMAO Q1 2026 Earnings EPS Surpasses Estimates by 38 Amid Steady Operations BLBD Q1 2026 Earnings EPS Beat Drives Stock Higher on Operational Strength CDE Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds SYPR Q3 2025 Earnings Return to Profitability with EPS of 002